The Daily Buyout
UndisclosedMergerHealthcare & Life SciencesCompleted

Lanterne Dx merges with Flagship Biosciences

CRO Lanterne Dx completed its merger with Ampersand-backed digital pathology firm Flagship Biosciences; the combined company keeps the Lanterne Dx name under CEO Jon Bishop.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

Following healthcare M&A?

The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.

Free · Unsubscribe anytime

See what you get →